Clinical Trials · NCT02693119
A Study Investigating the Safety, Tolerability, and Efficacy of Elamipretide Topical Ophthalmic Solution for Treatment of Leber's Hereditary Optic Neuropathy
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Stealth BioTherapeutics Inc.
- Enrollment
- 12
- Start date
- Mar 2016
- Locations
- 1 site, United States
- Primary endpoint
- Double Masked Period: Incidence of Ocular TEAEs